ARTICLEhttps://thejns.org/view/journals/j-neurosurg/aop/article-10.3171-2025.4.JNS243100/article-10.3171-2025.4.JNS243100.xmlOptimal imaging follow-up strategies for conservatively managed cerebral cavernous malformations: a cost-effectiveness analysis2025-08-26https://thejns.org/view/journals/j-neurosurg/aop/article-10.3171-2025.4.JNS243100/article-10.3171-2025.4.JNS243100.pdf2025-08-26Optimal imaging follow-up strategies for conservatively managed cerebral cavernous malformations: a cost-effectiveness analysishttps://thejns.org/view/journals/j-neurosurg/aop/article-10.3171-2025.3.JNS242797/article-10.3171-2025.3.JNS242797.xmlImpact of adjuvant radiation therapy on outcomes in grade 2 conventional chondrosarcoma2025-08-26https://thejns.org/view/journals/j-neurosurg/aop/article-10.3171-2025.3.JNS242797/article-10.3171-2025.3.JNS242797.pdf2025-08-26Impact of adjuvant radiation therapy on outcomes in grade 2 conventional chondrosarcomahttps://thejns.org/view/journals/j-neurosurg/aop/article-10.3171-2025.4.JNS243119/article-10.3171-2025.4.JNS243119.xmlLongitudinal neurocognitive outcomes and predictors after unilateral combined cerebral revascularization in adult moyamoya vasculopathy2025-08-26https://thejns.org/view/journals/j-neurosurg/aop/article-10.3171-2025.4.JNS243119/article-10.3171-2025.4.JNS243119.pdf2025-08-26Longitudinal neurocognitive outcomes and predictors after unilateral combined cerebral revascularization in adult moyamoya vasculopathyhttps://thejns.org/view/journals/j-neurosurg/aop/article-10.3171-2025.4.JNS243146/article-10.3171-2025.4.JNS243146.xmlUse of integrated spatial transcriptomics and histopathological analysis in adamantinomatous craniopharyngiomas to identify stromal cells as a new cellular source of leukemia inhibitory factor2025-08-26https://thejns.org/view/journals/j-neurosurg/aop/article-10.3171-2025.4.JNS243146/article-10.3171-2025.4.JNS243146.pdf2025-08-26Use of integrated spatial transcriptomics and histopathological analysis in adamantinomatous craniopharyngiomas to identify stromal cells as a new cellular source of leukemia inhibitory factor